<?xml version="1.0" encoding="UTF-8"?>
<ref id="B142">
 <label>142.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Omrani</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Saad</surname>
    <given-names>MM</given-names>
   </name>
   <name>
    <surname>Baig</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Bahloul</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Abdul-Matin</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Alaidaroos</surname>
    <given-names>AY</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study</article-title>. 
  <source>Lancet Infect Dis.</source> (
  <year>2014</year>) 
  <volume>14</volume>:
  <fpage>1090</fpage>â€“
  <lpage>5</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(14)70920-X</pub-id>
  <?supplied-pmid 25278221?>
  <pub-id pub-id-type="pmid">25278221</pub-id>
 </mixed-citation>
</ref>
